Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01423201 · ClinicalTrials.gov registry record
Transient Ischemic Attack (TIA) Triage and Evaluation of Stroke Risk
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 262
- Enrollment target
NCT01423201: Completed study, sponsored by Stanford University.
NCT01423201 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 262 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01423201 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 262 participants
- Enrollment target
Study Summary
Transient ischemic attack (TIA) is a transient neurological deficit (speech disturbance, weakness…), caused by temporary occlusion of a brain vessel by a blood clot that leaves no lasting effect. TIA diagnosis can be challenging and an expert stroke evaluation combined with magnetic resonance imaging (MRI) could improve the diagnosis accuracy. The risk of a debilitating stroke can be as high as 5% during the first 72 hrs after TIA. TIA characteristics (duration, type of symptoms, age of the patient), the presence of a significant narrowing of the neck vessels responsible for the patient's symptoms (symptomatic stenosis), and an abnormal MRI are associated with an increased risk of stroke. An emergent evaluation and treatment of TIA patients by a stroke specialist could reduce the risk of stroke to 2%. Stanford has implemented an expedited triage pathway for TIA patients combining a clinical evaluation by a stroke neurologist, an acute MRI of the brain and the vessels and a sampling of biomarkers (Lp-PLA2). The investigators are investigating the yield of this unique approach to improve TIA diagnosis, prognosis and secondary stroke prevention. The objective of this prospective cohort study is to determine which factors will help the physician to confirm the diagnosis of TIA and to define the risk of stroke after a TIA.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 262 participants |
| Start Date | 2010-09 |
| Est. Completion | 2017-11-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01423201
The ClinicalTrials.gov registry entry for NCT01423201 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 262 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01423201 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01423201 about?
NCT01423201 is a clinical study titled "Transient Ischemic Attack (TIA) Triage and Evaluation of Stroke Risk". Transient ischemic attack (TIA) is a transient neurological deficit (speech disturbance, weakness…), caused by temporary occlusion of a brain vessel by a blood clot that leaves no lasting effect. TIA diagnosis can be challenging and an expert stroke evaluation combined with magnetic resonance imagi...
What is the current status of trial NCT01423201?
This trial is currently completed. The enrollment target is 262 participants. The study started on 2010-09. Estimated completion is 2017-11-02.
Who is sponsoring clinical trial NCT01423201?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.